Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
Intellia Therapeutics (NTLA) Ownership - Who Owns Intellia Therapeutics?
2,750 Followers
Intellia Therapeutics (NTLA) Ownership Overview
18.91% Insiders
26.52% Mutual Funds
33.97% Other Institutional Investors
20.60% Public Companies and Individual Investors
The ownership structure of Intellia Therapeutics (NTLA) stock is a mix of institutional, retail and individual investors. Approximately 60.49% of the company’s stock is owned by Institutional Investors, 18.91% is owned by Insiders and 20.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 05, 2024 | Eliana Clark Evp, Cto | xxxxxxxxxxxxx | $19959 |
| Mar 05, 2024 | James Basta Evp & Gc | xxxxxxxxxxxxx | $75778 |
| Jan 05, 2024 | Eliana Clark Evp, Cto | xxxxxxxxxxxxx | $126707 |
| Jan 05, 2024 | Laura Sepp Lorenzino Evp, Chief Scientific Officer | xxxxxxxxxxxxx | $162973 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $113396 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $302315147 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,242,891 | Institution | 11.65% | 281,971,706 | |
| 10,989,282 | Institution | 11.39% | 275,611,193 | |
| 8,761,081 | Institution | 9.08% | 219,727,911 | |
| 8,013,043 | Institution | 8.31% | 200,967,118 | |
| 4,625,320 | Institution | 4.79% | 116,003,026 | |
| 3,296,787 | Institution | 3.42% | 82,683,418 | |
| 2,340,153 | Institution | 2.43% | 58,691,037 | |
| 1,905,000 | Institution | 1.97% | 47,777,400 | |
| 1,163,722 | Institution | 1.21% | 29,186,148 | |
| 967,732 | Institution | 1.00% | 24,270,719 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,013,043 | Institution | 8.31% | 200,967,118 | |
| 3,296,787 | Institution | 3.42% | 82,683,418 | |
| 1,905,000 | Institution | 1.97% | 47,777,400 | |
| 1,163,722 | Institution | 1.21% | 29,186,148 | |
| 967,732 | Institution | 1.00% | 24,270,719 | |
| 934,307 | Institution | 0.97% | 23,432,420 | |
| 727,740 | Institution | 0.75% | 18,251,719 | |
| 652,320 | Institution | 0.68% | 16,360,186 | |
| 648,627 | Institution | 0.67% | 16,267,565 | |
| 447,447 | Institution | 0.46% | 11,221,971 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,618,664 | Institution | 8.93% | 216,156,093 | |
| 2,624,227 | Institution | 2.72% | 65,815,613 | |
| 2,554,019 | Institution | 2.65% | 64,054,797 | |
| 2,851,658 | Institution | 2.96% | 63,820,106 | |
| 2,143,334 | Institution | 2.22% | 55,919,584 | |
| 2,303,821 | Institution | 2.39% | 51,559,514 | |
| 1,489,860 | Institution | 1.54% | 33,343,067 | |
| 1,297,758 | Institution | 1.35% | 29,043,824 | |
| 898,517 | Institution | 0.93% | 22,534,806 | |
| 700,246 | Institution | 0.73% | 17,562,170 |
FAQ
Who Owns Intellia Therapeutics (NTLA)?
According to the latest TipRanks data, approximately 33.97% of the company's stock is held by institutional investors, 18.91% is held by insiders, and 20.60% is held by retail investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.97% of Intellia Therapeutics (NTLA) stock is held by institutional investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.60% of Intellia Therapeutics (NTLA) stock is held by retail investors.
Who owns the most shares of Intellia Therapeutics (NTLA)?
ARK owns the most shares of Intellia Therapeutics (NTLA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.